Meagher Craig, Tang Qizhi, Fife Brian T, Bour-Jordan Helene, Wu Jenny, Pardoux Cecile, Bi Mingying, Melli Kristin, Bluestone Jeffrey A
Diabetes Center, University of California, San Francisco, CA 94143, USA.
J Immunol. 2008 Jun 15;180(12):7793-803. doi: 10.4049/jimmunol.180.12.7793.
Autoimmune pancreatitis (AIP) is a heterogeneous autoimmune disease in humans characterized by a progressive lymphocytic and plasmacytic infiltrate in the exocrine pancreas. In this study, we report that regulatory T cell-deficient NOD.CD28KO mice spontaneously develop AIP that closely resembles the human disease. NOD mouse AIP was associated with severe periductal and parenchymal inflammation of the exocrine pancreas by CD4(+) T cells, CD8(+) T cells, and B cells. Spleen CD4(+) T cells were found to be both necessary and sufficient for the development of AIP. Autoantibodies and autoreactive T cells from affected mice recognized a approximately 50-kDa protein identified as pancreatic amylase. Importantly, administration of tolerogenic amylase-coupled fixed spleen cells significantly ameliorated disease severity, suggesting that this protein functions as a key autoantigen. The establishment and characterization of this spontaneous pancreatic amylase-specific AIP in regulatory T cell-deficient NOD.CD28KO mice provides an excellent model for the study of disease pathogenesis and development of new therapies for human autoimmune pancreatitis.
自身免疫性胰腺炎(AIP)是一种人类异质性自身免疫疾病,其特征为外分泌胰腺中出现进行性淋巴细胞和浆细胞浸润。在本研究中,我们报告了调节性T细胞缺陷的NOD.CD28KO小鼠会自发发生与人类疾病极为相似的AIP。NOD小鼠AIP与外分泌胰腺中由CD4(+) T细胞、CD8(+) T细胞和B细胞引起的严重导管周围和实质炎症相关。研究发现,脾脏CD4(+) T细胞对于AIP的发生发展既是必需的也是充分的。患病小鼠的自身抗体和自身反应性T细胞识别出一种约50 kDa的蛋白质,鉴定为胰腺淀粉酶。重要的是,给予耐受性淀粉酶偶联的固定脾脏细胞可显著改善疾病严重程度,这表明该蛋白质作为关键自身抗原发挥作用。在调节性T细胞缺陷的NOD.CD28KO小鼠中建立并表征这种自发性胰腺淀粉酶特异性AIP,为研究人类自身免疫性胰腺炎的疾病发病机制和开发新疗法提供了一个极佳的模型。